Results 1 to 10 of about 12,093 (219)

Appendectomy Mitigates Coxsackievirus B3−Induced Viral Myocarditis [PDF]

open access: yesViruses, 2023
Appendix has a distinct abundance of lymphatic cells and serves as a reservoir of microbiota which helps to replenish the large intestine with healthy flora.
Chengrui Niu, Wei Xu, Sidong Xiong
doaj   +4 more sources

N6-Methyladenosine Positively Regulates Coxsackievirus B3 Replication [PDF]

open access: yesViruses
Enteroviruses such as coxsackievirus B3 are identified as a common cause of viral myocarditis, but the potential mechanism of its replication and pathogenesis are largely unknown.
Hainian Zhao   +9 more
doaj   +4 more sources

Coxsackievirus B3—Its Potential as an Oncolytic Virus [PDF]

open access: yesViruses, 2021
Oncolytic virotherapy represents one of the most advanced strategies to treat otherwise untreatable types of cancer. Despite encouraging developments in recent years, the limited fraction of patients responding to therapy has demonstrated the need to ...
Anja Geisler   +4 more
doaj   +4 more sources

CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis. [PDF]

open access: yesPLoS ONE, 2017
Studies on inflammatory disorders elucidated the pivotal role of the CX3CL1/CX3CR1 axis with respect to the pathophysiology and diseases progression. Coxsackievirus B3 (CVB3)-induced myocarditis is associated with severe cardiac inflammation, which may ...
Irene Müller   +12 more
doaj   +3 more sources

Coxsackievirus B3, Shandong Province, China, 1990–2010

open access: yesEmerging Infectious Diseases, 2012
To determine the cause of a 2008 outbreak of aseptic meningitis in Shandong Province, China, we analyzed samples from outbreak patients and coxsackievirus B3 samples collected during 1990–2010 surveillance. The cause of the outbreak was coxsackievirus B3,
Zexin Tao   +9 more
doaj   +3 more sources

ROS-Mediated Necroptosis Promotes Coxsackievirus B3 Replication and Myocardial Injury [PDF]

open access: yesMicroorganisms
Coxsackievirus B3 (CVB3) is a primary causative agent of viral myocarditis (VMC), which can lead to both acute and chronic cardiac inflammation accompanied by progressive heart failure and arrhythmias.
Junbo Huang   +9 more
doaj   +2 more sources

The protective effects of ivabradine in preventing progression from viral myocarditis to dilated cardiomyopathy [PDF]

open access: yesFrontiers in Pharmacology, 2016
To study the beneficial effects of ivabradine in dilated cardiomyopathy mice, which evolved from coxsackievirus B3-induced chronic viral myocarditis. Four-to-five-week-old male balb/c mice were inoculated intraperitoneally with coxsackievirus B3 (Strain ...
Li Yue-Chun   +8 more
doaj   +3 more sources

Comprehensive profiling of neutralizing polyclonal sera targeting coxsackievirus B3 [PDF]

open access: yesNature Communications, 2023
Despite their fundamental role in resolving viral infections, our understanding of how polyclonal neutralizing antibody responses target non-enveloped viruses remains limited.
Beatriz Álvarez-Rodríguez   +2 more
doaj   +2 more sources

IL-9 inhibits viral replication in Coxsackievirus B3-induced myocarditis [PDF]

open access: yesFrontiers in Immunology, 2016
Myocardial injuries in viral myocarditis (VMC) are caused by viral infection and related autoimmune disorders. Recent studies suggest that IL-9 mediated both antimicrobial immune and autoimmune responses in addition to allergic diseases.
Miao Yu   +6 more
doaj   +3 more sources

Targeting Viperin prevents coxsackievirus B3-induced acute heart failure [PDF]

open access: yesCell Discovery
Coxsackievirus B3 (CVB3)-induced acute heart failure (AHF) is a common cause of cardiogenic death in young- and middle-aged people. However, the key molecular events linking CVB3 to AHF remain largely unknown, resulting in a lack of targeted therapy ...
Yukang Yuan   +21 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy